• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21934 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome
2015     NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis
2004     Andalusian Health Technology Assessment Area (AETSA) Systematic review: evaluation methodology of health services based on telemedicine and e-health
2009     VA Technology Assessment Program (VATAP) Systematic reviews for amyotrophic lateral sclerosis
2009     VA Technology Assessment Program (VATAP) Systematic reviews for localized prostate cancer
2009     VA Technology Assessment Program (VATAP) Systematic reviews for nurse-led primary care
2007     VA Technology Assessment Program (VATAP) Systematic reviews for patient-centered care
2010     VA Technology Assessment Program (VATAP) Systematic reviews for patient-centered care: update
2009     VA Technology Assessment Program (VATAP) Systematic reviews for podiatry
2001     NIHR Health Technology Assessment programme Systematic reviews of (i) comparative studies of depot neuroleptic drugs, and (ii) studies of oral vs depot neuroleptic agents for patients with schizophrenia: clinical, social and economic outcomes- systematic review
2014     NIHR Health Technology Assessment programme Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men
2006     NIHR Health Technology Assessment programme Systematic reviews of clinical decision tools for acute abdominal pain
2012     Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robot-assisted surgery: update
2013     Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robotic surgery in obstetrics and gynecology
2010     Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robotic-assisted surgery
2007     VA Technology Assessment Program (VATAP) Systematic reviews of strategies for changing clinician behavior to improve patient outcomes
2010     VA Technology Assessment Program (VATAP) Systematic reviews of strategies for changing clinician behavior to improve patient outcomes
2007     NIHR Health Technology Assessment programme Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007     NIHR Health Technology Assessment programme Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2001     NIHR Health Technology Assessment programme Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) Acute day hospital versus admission; (2) Vocational rehabilitation; (3) Day hospital versus outpatient care
1998     NIHR Health Technology Assessment programme Systematic reviews of trials and other studies
1999     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds
2000     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration
2001     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy
2010     Agency for Healthcare Research and Quality (AHRQ) Systematic reviews on selected pharmacogenetic tests for cancer treatment: CYP2D6 for Tamoxifen in breast cancer, KRAS for anti-EGFR antibodies in colorectal cancer, and BCR-ABL1 for tyrosine kinase inhibitors in chronic myeloid leukemia
2005     Andalusian Health Technology Assessment Area (AETSA) Systemic active immunotherapy for the treatment of malignant glioma
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Systemic thrombolysis and endovascular therapy for large vessel occlusion acute ischemic stroke
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Systemic thrombolysis by alteplase for acute ischemic stroke
1996     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Systemic thrombolytics in acute ischemic stroke
2011     Penn Medicine Center for Evidence-based Practice (CEP) Systems for early warning of patient deterioration
2002     Agency for Healthcare Research and Quality (AHRQ) Systems to rate the strength of scientific evidence
2002     NIHR Horizon Scanning Centre (NIHR HSC) T-20 for HIV - horizon scanning review
2008     Institute for Clinical Effectiveness and Health Policy (IECS) T-cell vaccines for the treatment of multiple sclerosis
2014     NIHR Health Technology Assessment programme T-DM1 for treating HER2-positive, unresectable locally advanced or metastatic breast cancer after treatment with trastuzumab and a taxane
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) T-score as a measurement to assess the 10-year fracture risk: a review of the clinical evidence
2010     Adelaide Health Technology Assessment (AHTA) T-Stat for the detection of ischaemia
2009     Adelaide Health Technology Assessment (AHTA) T-Stat system for the detection of tissue ischemia
2014     Malaysian Health Technology Assessment (MaHTAS) T.SPOT.TB assay – an update
2013     NIHR Horizon Scanning Centre (NIHR HSC) T30 neurostimulator device for chronic tonal subjective tinnitus
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tabalumab for systemic lupus erythematosus
2023     National Institute for Health and Care Excellence (NICE) Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal). NICE technology appraisal guidance 923
2000     VA Technology Assessment Program (VATAP) Tablet splitting
2016     NIHR Health Technology Assessment programme Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme a randomised controlled trial and economic evaluation
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tacrolimus
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®)
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Envarsus®)
1997     Wessex Institute for Health Research and Development (WIHRD) Tacrolimus after kidney transplantation
2004     Quality Improvement Scotland (NHS QIS ) Tacrolimus and pimecrolimus for atopic eczema
2004     National Institute for Health and Care Excellence (NICE) Tacrolimus and pimecrolimus for atopic eczema
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Tacrolimus for Crohn's disease
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tacrolimus ointment for the treatment of atopic dermatitis
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus prolonged-release (Advagraf®)
2002     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) TACTICS: Transfusion Associated Complications or Transfusion Induced Complications - primary research
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Tactile devices in audiology
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Tactile devices in audiology
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tadalafil (Cialis) for Duchenne muscular dystrophy
2010     NIHR Horizon Scanning Centre (NIHR HSC) Tafamidis for transthyretin amyloid polyneuropathy
2024     Agency for Care Effectiveness (ACE) Tafamidis for treating transthyretin amyloid cardiomyopathy
2013     HAYES, Inc. Tai chi for improving balance and function in patients with parkinson's disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2024     National Institute for Health and Care Excellence (NICE) Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations. NICE technology appraisal guidance 952
2016     HAYES, Inc. Talimogene laherparepvec (T-VEC; Imlygic) for treatment of unresectable melanoma lesions
2007     Adelaide Health Technology Assessment (AHTA) Tam Pap for self testing of HPV
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tamaflu (R) (oseltamivir phosphate)
1999     ECRI Tamoxifen for reduction of breast cancer incidence in healthy women at high risk
2011     HAYES, Inc. Tandem autologous peripheral blood stem cell transplantation for neuroblastoma
2015     HAYES, Inc. Tandem autologous stem cell transplant for Hodgkin lymphoma
2007     HAYES, Inc. Tandem mass spectrometry for metabolic disease screening of newborns
2002     HAYES, Inc. Tandem mass spectrometry for metabolic screening of newborns
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tap water home haemodialysis systems for end stage renal failure: horizon scanning technology briefing
2009     NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) for severe acute pain
2009     NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) prolonged-release for severe chronic pain
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tapentadol prolonged release (Palexia® SR)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Taranabant (MK-0364) for obesity
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tarenflurbil (Flurizan, R-Flurbiprofen) for Alzheimer’s disease – mild
2020     Institute for Clinical and Economic Review (ICER) Targeted immune modulators for ulcerative colitis: effectiveness and value
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors
2008     Adelaide Health Technology Assessment (AHTA) Targeted screening for abdominal aortic aneurysm
2010     Adelaide Health Technology Assessment (AHTA) Targeted screening for cardiovascular risk for all adults between 40-74 years
2020     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with hormonal therapy as a first-line treatment for HR+ and HER2- metastatic breast cancer
2021     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with neoadjuvant chemotherapy for HER2-positive breast cancer and economic evaluation
2023     National Institute for Health and Care Excellence (NICE) Targeted-release budesonide for treating primary IgA nephropathy. NICE technology appraisal guidance 937
2014     NIHR Health Services and Delivery Research programme Targeting the Use of Reminders and Notifications for Uptake by Populations (TURNUP): a systematic review and evidence synthesis
2022     NIHR Health Technology Assessment programme Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)
2022     NIHR Health Technology Assessment programme TARGIT-B: An international randomised controlled trial to compare targeted intra-operative radiotherapy boost with conventional external beam radiotherapy boost after lumpectomy for breast cancer in women with a high risk of local recurrence
2006     NIHR Horizon Scanning Centre (NIHR HSC) Taribavirin hydrochloride for chronic hepatitis C virus: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Taspoglutide for type 2 diabetes mellitus - add-on therapy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tasquinimod for chemotherapy naïve, metastatic hormone-relapsed prostate cancer
2001     NIHR Health Technology Assessment programme Taxanes (breast cancer): update
2001     NIHR Health Technology Assessment programme Taxanes (ovarian cancer): update
2007     NIHR Health Technology Assessment programme Taxanes for the adjuvant treatment early breast cancer: systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Taxanes for the adjuvant treatment early breast cancer: systematic review and economic evaluation
2000     HAYES, Inc. Taxol treatment for breast cancer
2000     HAYES, Inc. Taxol treatment for non-small-cell lung cancer
2000     HAYES, Inc. Taxol treatment for ovarian cancer
2011     HAYES, Inc. Tay-Sachs Disease (TSD) testing in individuals of non–ashkenazi jewish origin
2011     HAYES, Inc. Taylor spatial frame (Smith&Nephew Inc.) for posttraumatic lower limb deformity
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tc-99m labelled antibody fragment for osteomyelitis
2014     Health Quality Ontario (HQO) Team-based models for end-of-life care: an evidence-based analysis